openPR Logo
Press release

Antibacterial Coatings Market rise in orthopedic, dental and cardiac disorders, and growth in affordability in developing economies are projected to supplement the market growth

04-17-2019 09:59 AM CET | Health & Medicine

Press release from: Allied Market Research

Antibacterial Coatings Market

Antibacterial Coatings Market

Antibacterial Coatings Market was valued at $120.22 million in 2016, and is projected to reach $343.16 million by 2023, registering a CAGR of 16.1% from 2017 to 2023. Metallic coatings segment held around three-fourths share of the total market in 2016.

Antibacterial coatings are materials that prevent the bacterial adhesion and biofilm formation on the surface of medical implants. In addition, they act as anti-thrombotic coating, which prevents the formation of thrombus during bacterial infections after the surgery in patient. So accordingly, medical implants are coated with antibacterial coating to obtain an ideal potent surface that can provide protection against the pathogens.

The major companies profiled in the report are aap Implantate AG, AST Products, Inc., BioCote Ltd, Covalon Technologies Ltd., DOT GmbH, Harland Medical Systems Inc., Hydromer, Inc., Koninklijke DSM N.V., Sciessent LLC, and Specialty Coating Systems, Inc.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4462

The major factors that drive the global antibacterial coatings market for medical implants are increase in incidence of implant-associated infections, demand for implantable devices, rise in bone related and cardiovascular disorders, and growth of geriatric population. However, high cost of antibacterial coatings, few drawbacks of silver coatings, and time-consuming regulatory approvals are expected to restrain the market growth. Conversely, growth in need of better healthcare services in the emerging markets, such as China and India, and development of novel antibacterial coatings are expected to provide lucrative opportunities to the market players.

The metallic coatings segment occupied the highest share in 2016, owing to the usage applicability and availability of metallic coatings in medical & clinical settings. Furthermore, the metallic coating segment is expected continue its dominance in the market during the forecast period. The utilization rate of antibacterial coating for cardiac implants is high, however orthopedic implants is expected to grow at a high CAGR during the forecast period. This is attributed to increase in incidence of bone related disorders such as fractures or replacement of joints leading rise in use of orthopedic implants.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4462

Key Findings of the Antibacterial Coatings Market:
• Non-metallic coating segment is expected to grow at a CAGR of 13.8% from 2017 to 2023.
• Metallic coatings segment accounted for around three-fourths share of the global antibacterial coatings market for medical implants in 2016.
• Cardiac implants segment accounted for more than one-fifth share of the global antibacterial coatings market for medical implants in 2016.
• Asia-Pacific is expected to grow at the highest CAGR of 17.4%, from 2017 to 2023.
• North America accounted for around one-third share of the global antibacterial coatings market for medical implants in 2016.

North America was the leading revenue contributor to the global antibacterial coatings market for medical implants. This is attributed to the early adoption of technologically advanced coating and high use of implantable devices due to rise in incidence of chronic disorders. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and growth in awareness about implantation surgeries.

Access Full Summery @ https://www.alliedmarketresearch.com/antibacterial-coatings-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibacterial Coatings Market rise in orthopedic, dental and cardiac disorders, and growth in affordability in developing economies are projected to supplement the market growth here

News-ID: 1706634 • Views: 213

More Releases from Allied Market Research

Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 …
According to a new report published by Allied Market Research, titled, “Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market by Product, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global Diphtheria, Tetanus, and Pertussis Vaccine market was valued at $ 4,758.8 million in 2019 and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1% from 2020-2027. The DTaP segment accounted for major
Burn Care Market Expected to Reach $3,134 Million by 2027
According to a new report published by Allied Market Research, titled, “Burn care Market by Product, Depth of Burn, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global burn care market size was valued at $1,992 million in 2019, and is projected to reach $3,134 million by 2027, growing at a CAGR of 5.6% from 2020 to 2027. Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4395 Burns are injuries
Drug Delivery Devices Market projected to Cross $26.7 Billion by 2026
Drug Delivery Devices Market size was valued at $19 billion in 2018, and is expected to reach $26.7 billion by 2026, registering a CAGR of 4.3% from 2019 to 2026. Drugs are used to improve health and to extend lives. However, the medications can be taken in various ways, including by swallowing, by absorption, by inhalation, through the skin, and by intravenous injection. For this, the drug delivery devices are developed,
Pharmaceutical Filtration Market on Position to Hit $7.74 Billion by 2026
Pharmaceutical filtration is defined as a filtration process to separate suspended particles from a medium or solution by passing them through a membrane. They reduce or eliminate the bacteria or other microorganisms in process components. The filtration process can be combined with other pharmaceutical manufacturing operations. Pharmaceutical filters are used in the production of small molecule ingredients such as active pharmaceutical ingredients (APIs) and pharmaceutical excipients. In addition, it is

All 5 Releases


More Releases for Antibacterial

Global Antibacterial Drugs Market Research Report
This report studies the global Antibacterial Drugs market status and forecast, categorizes the global Antibacterial Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bayer AG Pfizer Inc. Sanofi GlaxoSmithKline Plc. (GSK) Merck & Co., Inc. AstraZeneca Johnson and Johnson Bristol
Antibacterial Drugs Market: Regional & Competitive Analysis
The global antibacterial drugs market, according to TMR, could expand at a CAGR of 1.30% between 2015 and 2023 to achieve a revenue valuation of nearly US$38.9 bn by the final forecast year. Although β-lactams had dominated the market in the past with a larger share, the drug class could lose its share to miscellaneous antibacterials, which are projected to rise at a higher growth rate during the forecast period.
Global Antibacterial Drugs Sales Market Report 2017
Qyresearchreports include new market research report "Global Antibacterial Drugs Sales Market Report 2017" to its huge collection of research reports. The report on global Antibacterial Drugs presents a detailed overview of the current market dynamics and emerging trends and opportunities. Various factors and trends are expected to favorably impact the Antibacterial Drugs market over the forecast period 2017-2022. The study provides comprehensive insights into notable trends and opportunities shaping the market
Animal Antibacterial Peptide Market Analysis – 2024
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and
Animal Antibacterial Peptide 2024 Market Research Report
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and
Antibacterial Drugs Market - Global Industry Insights 2024
Prevalence of bacterial infections and diseases is especially high in third world countries and significantly hampers quality of life across the globe. Further adding to the woes of the affected population is the increasing strains of bacteria that are resistant to conventional antibacterial drugs. The epidemic of antibacterial resistance has spurred interest among the global healthcare organizations and a few pharmaceutical companies and research institutes to develop next-generation antibacterial